Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, DIL has informed that the Notice of the Meeting of Secured Creditors and Unsecured Creditors of the Company dated June 7, 2019 was sent through courier on June 7, 2019 for seeking approval for the Scheme of Amalgamation of Fermenta Biotech (the Transferor Company) with DIL (the Transferee Company) and their respective shareholders under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013. The above Notices to Secured Creditors and Unsecured Creditors of the Company were sent pursuant to the directions of the Honble National Company Law Tribunal, Bench at Mumbai in order dated June 6, 2019. The copies of the above notices are enclosed herewith for information and record.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1804.50 |
Dr. Reddys Lab | 1201.45 |
Cipla | 1551.30 |
Lupin | 2104.90 |
Zydus Lifesciences | 879.85 |
View more.. |